Cargando…
Natural killer cell-based immunotherapy for lung cancer: Challenges and perspectives
Despite the marked success of molecular targeted therapy in lung cancer in this era of personalized medicine, its efficacy has been limited by the presence of resistance mechanisms. The prognosis of patients with lung cancer remains poor, and there is an unmet need to develop more effective therapie...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444189/ https://www.ncbi.nlm.nih.gov/pubmed/34498710 http://dx.doi.org/10.3892/or.2021.8183 |